RxResults
PrivateLast Round
VC Round
Sep 3, 2014
Company Overview
RxResults is a healthcare services company that provides evidence-based pharmacy risk management and drug cost containment solutions for self-insured health plans and employers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Compliance & Risk, Business Intelligence
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxResults Comparables
Compare RxResults with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VIVIO Health | 83% | |
| Archimedes | 81% | |
| Payer Matrix, LLC | 79% | |
RxResults Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 3, 2014 |
RxResults Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ansley Equity Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2025
Monthly visitors increased 36% MoM, reaching 3.8K.
- May 2, 2025
Monthly visitors grew 219% MoM, reaching 2.3K.
RxResults Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxResults's valuation, stock price, and market status.